Yue Feng

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes

James Mu, John Woods, Yun-Ping Zhou et al. · Diabetes · 2006 · 450 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Blockers of the Delayed-Rectifier Potassium Current in Pancreatic β-Cells Enhance Glucose-Dependent Insulin Secretion

James Herrington, Yun-Ping Zhou, Randal M. Bugianesi et al. · Diabetes · 2006 · 167 citations · Full text

Medicine, Pharmacology, Physiology +17

Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice

Carina P. Tan, Yue Feng, Yun-Ping Zhou et al. · Diabetes · 2008 · 164 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes

James Mu, Aleksandr Petrov, George J. Eiermann et al. · European Journal of Pharmacology · 2009 · 134 citations

Medicine, Endocrinology, Pharmacology +17

Discovery of <i>N</i>-[(1<i>S</i>,2<i>S</i>)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

Linus S. Lin, Thomas J. Lanza, James P. Jewell et al. · Journal of Medicinal Chemistry · 2006 · 122 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12